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Vasken Dilsizian, MD,* Jagat Narula, MD, PHDyH eart failure patients with left ventricular(LV) ejection fractions of <35% who areon optimal medical therapy with QRS
durations of $120 ms on surface electrocardiography
have derived clinical beneﬁt from cardiac resynch-
ronization therapy (CRT). Although this well-
established and guideline-recommended treatment
has shown reductions in heart failure progression
and risk for ventricular tachyarrhythmias, there are
also shortcomings. Nearly one-third of patients with
CRT implants fail to show clinical beneﬁt. Although
potential explanations for the lack of response to
CRT may be multifactorial, one of the most important
prerequisites for successful CRT is proper LV lead
placement. And that can be technically challenging.
LV lead placement to deliver CRT typically in-
volves cannulating the coronary sinus, performing
coronary venous angiography, selecting a target vein,
and advancing the pacing lead into the selected vein
to achieve adequate resynchronization. Although it is
still an evolving art, the success rate of CRT has been
observed to be inﬂuenced by the contraction pattern
and scar burden of the left ventricle, particularly in
ischemic heart disease, as well as the relationship
between LV pacing lead position and the area of
electromechanical late activation. Thus, to guide LV
lead placement, it is important for the operator to
visualize both the myocardium and LV venous anat-
omy. In prior clinical trials, in which 2-dimensional
visual correspondence of ﬂuoroscopic venograms
and echocardiographic views have been applied, one-
third of patients had leads placed in incorrect posi-
tions. Despite a skillful technique, a lead implanter
may not necessarily colocalize the venous anatomyFrom the *University of Maryland School of Medicine, Baltimore,
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relationships relevant to the contents of this paper to disclose.with the myocardial segment, or perhaps the
optimized LV lead position on the myocardial wall
may not have a suitable venous branch for lead
placement.
Myocardial perfusion imaging with either single-
photon emission computed tomography or positron
emission tomography is ideally suited for differen-
tiating hypoperfused scarred myocardium from
viable myocardium; these modalities also allow the
assessment of regional and global dyssynchrony (1).
Given that changes in LV lead position of as little as
20 mm could affect response to CRT, the develop-
ment of a novel 3-dimensional (3D) toolkit, pre-
sented in this issue of iJACC, that fuses LV venous
anatomy on ﬂuoroscopic venograms with LV epicar-
dial surface on single-photon emission computed
tomographic myocardial perfusion for image-guided
lead placement is a welcome addition to our arma-
mentarium (2,3). The clinical feasibility of the 3D
toolkit was tested and conﬁrmed in a prospective
image-guided LV lead placement in a patient during
CRT in the cardiac catheterization laboratory. This
integrated imaging approach represents a step for-
ward, and the approach may continue to evolve as
its clinical utility is tested in larger randomized pa-
tient population with a control and/or comparator
group to assess patient outcomes. If validated, the
potential of using 3D image-guided approach to
improve the accuracy of lead placement can be
signiﬁcant.
The past several years have produced tremendous
growth and expansion in the ﬁeld of cardiac imaging.
Along with this growth has come a concomitant
appreciation for the importance of image-guided
therapeutics. Techniques that guide accurate lead
positioning might facilitate the progress and devel-
opment of a more personalized lead placement
strategy on the basis of the underlying myocardial
pathologic substrate. However, such techniques can
be useful only if they ultimately improve clinical
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1290management and patient outcomes. Therefore, we
applaud the ongoing clinical trials of advanced
image-guided techniques that provide 3D navigability
to optimize LV lead position to ﬁnd the “sweet spot”
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